Following Gubra's Annual General Meeting 2025 taking place earlier today we are pleased to confirm some exciting changes to the Board welcoming new perspectives to support the journey ahead.As ...

AUSTIN, TEXAS / ACCESS Newswire / April 3, 2025 / The Piazza Center proudly announces that board-certified plastic surgeon Dr. Rocco Piazza has been selected as one of the few elite plastic surgeons ...

GERMANTOWN, TENNESSEE / ACCESS Newswire / April 3, 2025 / Travel Nurses, Inc. entered a partnership with Souled Outside ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...

The global fecal calprotectin test market is on a trajectory of substantial growth, with projections estimating an increase ...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has released new findings on data-driven innovation and AI in life sciences in ...

Honeywell (NASDAQ: HON) today introduced TrackWise Manufacturing, an artificial intelligence (AI)-assisted, cloud-native platform designed to transform how life sciences companies manage, automate and ...

Averoa, a biopharmaceutical company bringing innovative therapeutic solutions to people with renal diseases, today announces a positive opinion from the European Medicines Agency (EMA)’s Committee for ...

CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have successfully concluded negotiations on the reimbursement price of HEMGENIX®. This agreement marks ...

Scientists have developed a new transgene control system that shows early promise for treating rare brain disorder Rett syndrome.

Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream. The researchers, whose study is published ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces the launch of PRE-CISE, a Eurostars-funded research collaboration with Danish PreTT and TetraKit ...